How Dual Russell 2000 Index Additions At Anterix (ATEX) Have Changed Its Investment Story

Anterix Inc.

Anterix Inc.

ATEX

0.00

  • On 27 June 2026, Anterix Inc. (NasdaqCM: ATEX) was added to both the Russell 2000 Defensive Index and the Russell 2000 Growth-Defensive Index, marking its inclusion in two key benchmarks followed by institutional investors.
  • These index additions can matter for Anterix because they may influence passive fund allocations and broaden awareness of its 900 megahertz private broadband utility focus.
  • We’ll now examine how Anterix’s inclusion in the Russell 2000 Defensive and Russell 2000 Growth-Defensive indices could reshape its investment narrative.

AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Anterix Investment Narrative Recap

To own Anterix, you need to believe that private 900 megahertz broadband will become critical infrastructure for utilities and that the company can translate spectrum holdings into durable contracts and cash flows. Its addition to the Russell 2000 Defensive and Growth-Defensive indices may raise visibility and affect trading, but it does not materially alter the near term dependence on FCC progress for 10 megahertz expansion or the risk that alternative connectivity options capture more utility spending.

The recent FCC Report and Order that maximizes the 900 megahertz band for a 10 megahertz broadband configuration is more directly relevant to this index news. That decision underpins Anterix’s spectrum value story and supports contracts like those signed with NorthWestern Energy, TNMP and Benton PUD, which rely on this configuration. Together, regulatory clarity and early utility deals feed the main catalyst of converting spectrum into long term lease and service revenue.

Yet against that backdrop, investors should still watch how dependent the story is on favorable FCC timing and complex spectrum clearing...

Anterix's narrative projects $6.9 million revenue and $935.0 thousand earnings by 2028. This requires 5.3% yearly revenue growth and a $94.7 million earnings decrease from $95.6 million today.

Uncover how Anterix's forecasts yield a $55.33 fair value, a 48% downside to its current price.

Exploring Other Perspectives

ATEX 1-Year Stock Price Chart
ATEX 1-Year Stock Price Chart

By contrast, the most pessimistic analysts were assuming revenue growth of only about 2.6% a year and no profitability within three years, which is far more cautious than the baseline narrative. If you are weighing Anterix’s new index status against this backdrop, it is worth considering that these lower forecasts were set before the index inclusion and could shift as the story evolves.

Explore 3 other fair value estimates on Anterix - why the stock might be worth as much as 20% more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Anterix research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
  • Our free Anterix research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Anterix's overall financial health at a glance.

Seeking Other Investments?

Our top stock finds are flying under the radar-for now. Get in early:

  • Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
  • Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
  • Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.